Renaissance Technologies’s Galectin Therapeutics GALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
2022
Q2
$36K Sell
2022
Q1
$325K Sell
2021
Q4
$446K Buy
2021
Q3
$39K Sell
2021
Q2
$1.19M Buy
2021
Q1
$666K Buy
2020
Q4
$35K Buy
2020
Q2
Sell
2020
Q1
$39K Sell
2019
Q4
$112K Buy
2019
Q3
Sell
2019
Q2
$144K Buy
2018
Q3
Sell
2018
Q2
$237K Buy